SBT6050

· Silverback Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SBT6050, covering 2022-08-18 to 2022-08-18. Get the full timeline:

Most recent: Clinical Trial Update: A Safety and Activity Study of SBT6050 in Combination With Other HER2-directed Therapies for HER2-positive Cancers [Phase 1, Phase 2]

See pricing